Cochlear awaits clarification on application of US tariff
Open PDF
| Stock | Cochlear Ltd (COH.ASX) |
|---|---|
| Release Time | 3 Apr 2025, 9:37 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Cochlear awaits clarity on US tariff impact
Key Points
- Cochlear's products currently imported duty-free to US
- Awaiting details on new 10% tariff on Australian exports
- Update to be provided to market in due course
Full Summary
Cochlear Limited (ASX:COH) has referred to the announcement by the US Government on the introduction of a 10% tariff on exports to the US from Australia. The company notes that there are complexities in understanding the application of the new tariff, as Cochlear has long been importing its products under a chapter of the Harmonized Tariff Schedule of the United States that provides for duty-free importation on a range of products into the US, including hearing implants. Cochlear is expecting further detail in the US Customs and Border Protection Notice of Implementation, which is expected to be published in the next week. The company will provide an update to the market in due course.